eft ventricular (LV) thrombus formation is a complication of acute myocardial infarction (AMI) and it is more prevalent in patients with an anterior AMI, because of the extensive area of severe apical wall motion abnormality with stagnant flow. [1] [2] [3] Before the era of early revascularization (ie, intravenous thrombolysis or primary coronary intervention), LV thrombus developed in 39% of patients with a first anterior AMI. 4 Although recent studies report that the prevalence has decreased because of early revascularization, 5-9 LV thrombus formation is still a risk of arterial embolism in patients with anterior wall AMI. 6, 10 Apical contraction abnormalities with stagnant flow are important factors related to LV thrombus formation, but that alone is not sufficient to identify high-risk patients. Therefore, identification of additional risk factors may be useful. Recently, LV diastolic dysfunction and inflammatory reactions have been reported as associated with LV thrombus formation, 11-13 although reliable predictors have not yet been determined.
prospectively studied 82 consecutive patients (57 men, 65±9 years of age) with their first anterior AMI within 24 h of onset.
AMI was diagnosed based on the following 3 criteria: (1) persistent angina pectoris lasting >20 min; (2) elevation of total creatine kinase (CK) >2-fold the upper limit of normal, with significant elevation of the troponin T concentration; and (3) changes on electrocardiogram (ECG) consistent with either ST-elevation AMI (ST segment elevation >1 mm in at least 2 standard leads or >2 mm in at least 2 contiguous precordial leads) or ST segment depression >1 mm in 2 contiguous leads or inversion of the T waves of >1 mm in at least 3 contiguous leads (non ST-elevation myocardial infarction (MI)). This study was approved by the ethics committee of Ibaraki Seinan Medical Center Hospital. All patients gave written informed consent before participation.
Study Protocol
Heparin (300 IU/kg per day) was administered for the first 3 days, unless the patient had a contraindication for anticoagulant therapy. Aspirin (200 mg/day) was administered routinely and ticlopidine (200 mg/day) was added for patients who underwent percutaneous coronary intervention (PCI). The C-reactive protein (CRP) concentration was measured by latex photometric immunoassay at the time of admission and every 24 h thereafter until the peak value was confirmed. In addition, we measured the peak white blood cell (WBC) count and peak CK concentration at the time of admission and every 6 h.
Standard echocardiographic examinations were performed on admission (day 1), and at the patient's bedside in the coronary care unit (CCU) between days 5 and 7 using a Vivid 3 system (GE, Horten, Norway) equipped with a multifrequency transducer. To assess stagnant apical flow and the presence of apical thrombus, contrast echocardiographic examinations were performed using Levovist (Schering, Berlin, Germany) as the echo contrast agent with a system (Vivid 7, GE, Horten, Norway) equipped with a multi frequency transducer (M3S). All examinations were performed in our echo laboratory between days 15 and 20 following AMI.
The Killip score was used to assess the degree of congestive heart failure complicating AMI. To assess coronary risk factors, we determined serum total cholesterol, lowdensity lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and hemoglobin A1c concentration, history of smoking, and presence of hypertension (systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg, or treatment with antihypertensive agents).
Coronary Angiography and Intervention
The right and left coronary arteries were imaged by the femoral artery approach using a 5Fr catheter to identify the infarct-related coronary artery. Based on the angiographic results, PCI or coronary artery bypass grafting (CABG) was performed. In all patients undergoing PCI, the infarctrelated artery was analyzed after PCI, and contrast flow through the epicardial vessel during angiography was graded according to the standard Thrombolysis In Myocardial Infarction (TIMI) trial flow scale. 22 
Echocardiography
We used echocardiographic variables obtained at the bedside in the CCU on days 5-7. LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), and LV ejection fraction (EF) were measured using the modified Simpson's method following LV opacification. The wall motion score index (WMSI) was used to assess LV wall motion abnormalities. The LV wall was divided into 16 segments, and the wall motion in each segment was scored as follows: normal wall motion =0; hypokinesis =1; severe hypokinesis =2; akinesis =3, and dyskinesis =4. The WMSI was calculated by summation of individual segments scores divided by the number of interpreted segments. In addition, the apical WMSI was calculated as the average of apical 4-segment scores.
For the contrast echocardiographic examinations, a bolus of 3 ml of Levovist (300 mg/ml) was injected via the cubital vein. First, B-mode images of intraventricular flow were recorded in the apical long-axis view. We used a mechanical index of 1.2, and the focal zone was positioned in the middle of the LV. Stasis of apical blood flow was defined as the presence of stagnant apical flow identified in contrast images (Fig 1) . Next, LV opacification was performed and the images were obtained by intermittent image acquisition triggered at end-systole using ECG guidance.
LV thrombus was defined as a non-opacified, filling defect distinct from the opacified LV cavity (Fig 2) .
Statistical Analysis
Results are expressed as number (%) or the mean ± SD. Comparisons between groups were performed using Student's t-test for continuous variables and the chi-square test for categorical variables. A p-value <0.05 was considered indicative of statistical significance. The correlations between variables were evaluated by simple linear regression analysis. Multivariate logistic analysis was performed to identify independent predictors for LV thrombus. Receiver-operating characteristics (ROC) analysis was used to determine optimal cutoff value of the variables for prediction of patients with LV thrombus. The best cutoff value was defined as the point with the highest sum of sensitivity and specificity. The area under the ROC curve was used to quantify the ability to predict patients with LV thrombus. All clinical variables with a value of p<0.05 in the univariate analysis were tested. All calculations were performed using the Dr. SPSS II for Windows statistical program (SPSS Inc, Chicago, IL, USA).
Results
Seven patients were excluded because sequential echocadiographic examinations and full laboratory data could not be obtained due to infection (including pneumonia or sepsis) in 3, early cardiac death in 3, and collagen disease in 1. Finally, 75 patients (53 men, 66±11 years) were studied.
Heparin was administered to 70 patients (93%); 5 patients did not receive heparin because of the presence of pericardial effusion or bleeding complications.
Diagnostic coronary angiography was performed in 73 patients: immediately after admission in 67 patients, and electively in 6 patients. PCI was performed in 67 patients, CABG in 4 patients, and thrombolysis with tissue-type plasminogen activator was performed in 2 patients.
In the standard echocardiographic examinations, LV thrombus was identified within 7 days of onset in 4 patients (5.3%) in the CCU and after 14 days in 10 patients (13%) in the echo laboratory. Using contrast echocardiography, optimal images were obtained in 70 patients (93.3%). Newly diagnosed LV thrombi were identified in 5 patients and finally in a total of 15 patients (20%). All thrombi were located in the LV apex. In 3 patients in whom the presence of LV thrombus could not be diagnosed with standard echocardiogarhy, contrast echocardiography confirmed the absence of LV thrombus.
Characteristics of the patients with and without LV thrombus are summarized in Table 1 . There were no differences with respect to age, gender, interval from symptom onset to admission, coronary risk factors, peak WBC count, or revascularization with PCI or CABG. The peak CK concentration was higher in patients with LV thrombus than in those without LV thrombus (6,214±3,170 vs 2,910± 2,463 mg/dl, p=0.002). In addition, the peak CRP concentration was higher in patients with LV thrombus than Killip class >1 was more prevalent in patients with LV thrombus (73% vs 56%, p=0.03). Patients with post-procedural TIMI 3 flow were less prevalent in the group with LV thrombus than in the one without LV thrombus, although this did not reach statistical significant (53% vs 78%, p= 0.07). The use of diuretics was more prevalent in patients in the LV thrombus group than in the group without LV thrombus (60.0% vs 26.3%, p=0.01).
Comparison of the Doppler ehocardiographic characteristics is summarized in Table 2 . A significantly greater LVEDV and LVESV, lower EF, higher total WMSI and apical WMSI were observed in patients with LV thrombus. Apical stagnant flow was more prevalent in patients with LV thrombus than in those without LV thrombus (93% vs 40%, p=0.001).
The correlations between these clinical variables are summarized in Table 3 . The correlation between peak CRP and peak CK concentrations was significant but weak (r=0.27, p=0.03). The Killip score correlated with the peak CRP concentration (r=0.45, p=0.001), but not the peak CK concentration.
In the univariate analysis, the presence of LV thrombus correlated significantly with the use of diuretics, Killip score >1, peak CRP concentration, CRP concentration at day 4, peak CK concentration, LVEDV, LVESV, EF, total WMSI, apical WMSI, and the presence of apical stagnant flow. In the multiple logistic regression analysis model (Model I), the peak CRP concentration was identified as the independent predictor for LV thrombus (p=0.009, odds ratio: 1.40, confidence interval: 1.09 to 1.81) ( Table 4 ). In another multiple logistic regression analysis model (Model II), in which the CRP concentration on day 4 was adopted instead of the peak CRP concentration, the CRP concentration on day 4 was identified as an independent predictor for LV thrombus (p=0.004, odds ratio: 1.37, confidence interval: 1.10 to 1.69). In both models, the correlations between the presence of LV thrombus and the apical WMSI were slightly not statistically significant (peak CRP, p=0.06; CRP on day 4, p=0.08) On the basis of the ROC analysis, the cutoff value of peak CRP concentration >10.7 mg/dl provided the best separation of patients with and without LV thrombus (sensivity 0.93, specificity 0.75, Fig 3) . Next, using the CRP concentration on day 4, a cutoff value >10.6 mg/dl provided the best separation of patients with and without LV thrombus as well as the peak concentration (sensivity 0.86, specificity 0.80, Fig 3) .
Discussion
The present study results show that the peak CRP concentration after AMI independently correlates with LV thrombus formation. Such a relationship has been shown in 2 previous studies. 12, 13 Anzai et al 13 showed that the cutoff point of peak CRP concentration as a predictor of LV thrombus was 20 mg/dl. The tissue necrosis following MI stimulates the inflammatory response, triggering cytokine cascades including interleukin (IL)-6. 23 Plasma CRP is produced only by hepatocytes, predominantly under the transcriptional control of the cytokine IL-6. Previous studies have shown that CRP localizes in infarcted human myocardium, and that CRP is co-deposited with activated complement within the area of MI. [24] [25] [26] [27] CRP can induce complement activation via the classical pathway. 28 An experimental study showed that human CRP enhances MI size by activating complement. 26 A postmortem study of infarcted human myocardium showed that CRP may function as a local pro-inflammatory mediator during AMI by activating complement. 27 In contrast, complement fixation on the cell surface can have a direct and immediate stimulatory effect on the coagulation cascade, with formation of a fibrin clot. 28 Although the relationship between coagulation and inflammation is complex and, as yet, not completely understood, the activated cytokine and coagulation cascade may be an important mechanism that supports the association of a higher serum CRP concentration with LV thrombus formation.
In patients with AMI, the factors related to increasing CRP concentration are not only myocardial necrosis. In the present study, 4 patients underwent CABG, all after day 7: 2 on day 7, 1 on day 8, and 1 on day 21. In all patients, the peak CRP concentration occurred before CABG. Therefore, in this study, CABG did not affect the peak CRP concentrations. However, if CABG were performed during the early phase, it might affect the results. Second, in patients with AMI, the inflammatory process of coronary plaque vulnerability may be associated with CRP concentration. Recently, Katayama et al 29 reported a relationship between inflammation and subacute thrombosis (SAT) in patients with AMI treated with primary coronary stenting. The peak CK concentration and EF did not differ between patients with and without SAT; however, the inflammatory markers, peak CRP and amyloid-A protein concentrations were higher in patients with SAT. In the present study, many patients were reperfused by primary stenting. Therefore, the CRP concentrations may also be partially related to coronary vulnerability and post-stent inflammation from coronary arterial wall injuries.
The present study demonstrated that LV thrombus formation is associated with various factors, including apical wall motion abnormalities, subsequent apical stagnant flow, and peak CRP concentration. Apical wall motion abnormalities and the subsequent stagnant flow play important roles in the development of LV thrombus. However, the present study results suggest that although these factors are necessary to develop LV thrombus, they are not the sufficient conditions, based on the strong relationship between inflammation and LV thrombus formation. The relationship between stagnant flow and LV thrombus formation may be modified by the inflammatory process after AMI. Patients with LV thrombus had a higher incidence of heart failure. Echocardiographic examination showed a decrease in EF and more prevalence of Killip class >1 in patients with LV thrombus. The Killip score correlated with the peak CRP concentration, not the peak CK concentration. In addition, the present study found a weak correlation between the peak CRP and CK concentrations, which were higher in patients with LV thrombus than in those without LV thrombus. The present results agree with previous studies that showed CRP responses after AMI predict complications, including LV thrombus and cardiac rupture, and clinical outcome, irrespective of infarct size assessed by CK or CK-MB concentrations. 12, [30] [31] [32] [33] Thus, CRP responses after AMI do not simply reflect the extent of myocardial necrosis. It may not be a simple indirect marker of inflammation, but be related to systemic or focal complications. 34 This study showed that the use of diuretics was more prevalent in patients in the LV thrombus group than in those without LV thrombus, which suggests that the use of diuretics induced hemoconcentration, which may lead to a hyper-coagulable state.
The rate of performing primary PCI rate is higher (75-94%) in Japan than elsewhere (5.5-49.6%). 35 Early revascularization for AMI has been shown to reduce the incidence of LV thrombosis. [5] [6] [7] [8] Greaves et al reported that the prevalence was 3.7% at 14 days, 7 and Chiarella et al reported a prevalence of 11.5% at 9±5 days in patients with anterior AMI. 8 However, the prevalence of patients with LV thrombus was higher (20%) in the present study than in those previous studies. It is clear that contrast echocardiography contributed to an increase in the detection of LV thrombus in the present study. Despite the advantage in diagnosing LV thrombus using contrast echocardiography, 18, 19 systematic studies of this technique have not been performed in patients with AMI. Previous studies have shown that standard echocardiography has a sensitivity of 92-95% and a specificity approaching 95% for detecting LV thrombus. 14, 15 However, because if the thrombi are small or laminated mural thrombi, it can be difficult to differentiate them from the underlying myocardium. In addition, fresh thrombus may be echolucent and can be missed without a thorough echocardiographic examination. Despite technical developments, such as second harmonic imaging, standard echocardiography is limited in its ability to adequately delineate the endocardial borders, 20 and 15-46% of echocardiograms are suboptimal in terms of quality for identifying thrombus. 17, 19 Unfortunately, in Japan contrast echocardiographic examination with Levovist cannot be performed within 2 weeks after the onset of AMI. Despite this limitation, in the present study contrast echocardiographic examinations performed 2 weeks after the onset of AMI identified new LV thrombi in 5 patients in whom they could not be found with standard echocardiography. Conversely, in 3 patients in whom the presence of LV thrombus could not be diagnosed with standard echocardiography, contrast echocardiography confirmed the absence of thrombus. Therefore, we may misdiagnose the presence of thrombus in some cases. Although we had limited time in which to perform LV opacification, we believe our results confirm the accuracy of LV opacification for detecting LV thrombus formation in patients with AMI.
We used contrast echocardiography to visualize apical stagnant flow. Although apical stagnant flow induced by apical severe asynergy is a mechanism responsible for LV thrombus formation, [1] [2] [3] it is difficult to visualize the apical flow by pulsed Doppler or color Doppler examination because of the limited ability to visualize apical flow dynamics. Beppu et al demonstrated in an experimental animal model that contrast echocardiography is useful for analyzing the intracavity flow pattern, and the relationship between stagnant apical flow and thrombus formation. 36 In the clinical setting, we developed this technique to assess the propagation of LV inflow, and recently demonstrated a relationship with apical stagnant flow. 21 In the present study, we confirmed the presence of apical stagnant flow in patients with thrombus formation, but LV thrombus may not be generated by apical stagnant flow alone.
We excluded patients with prior MI. In general, LV thrombi develop at the LV apex in patients with MI, so the occurrence of apical wall motion abnormalities is an important factor related to thrombus formation. To determine the relationship between LV thrombus formation and wall motion abnormalities, we only enrolled patients with their first anterior MI. However, if AMI with apical wall motion abnormalities occur in patients with prior heart disease, the LV function would be depressed to a greater extent and stagnant flow will develop. Therefore, in the future, we have to confirm whether the presence of prior heart disease is a risk factor for LV thrombus formation in patients with AMI.
Clinical Implication
The present study demonstrated that the CRP concentration on day 4 could be used to identify patients with LV thrombus. In the clinical setting, it may be a simple way of identifying patients at high risk for developing an LV thrombus, instead of using the peak concentration. Such patients should then undergo contrast echocardiographic examination to detect LV thrombus.
Study Limitations
LV thrombus formation after AMI is a dynamic process that tends to occur in the early phase. However, we could not perform contrast echocardiography early after AMI because in Japan contrast echocardiography with Levovist is contraindicated in patients with AMI within 14 days. Contrast echocardiography is useful for detecting LV thrombus in patients just admitted to an intensive care unit from whom optimal images for detecting thrombus may not be obtained. In future, we hope to be able to perform contrast echocardiography in the early stage of AMI.
Because of the small number of patients in this study, large population studies are necessary to confirm our results.
Conclusions
The present study showed that the peak CRP concentration or the concentration on day 4 is strongly associated with LV thrombus formation in patients with anterior AMI. The CRP concentration is a useful marker for identifying patients at high risk for LV thrombus formation. In such patients, we have to carefully perform echocardiographic examinations during the acute phase of AMI, but contrast echocardiography has the potential to accurately detect LV thrombus.
